Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R G Guttmann

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Neurology|August 2, 2008
MRI measures of temporoparietal regions show differential rates of atrophy during prodromal ADR S Desikan, B Fischl, H J Cabral, et al.
Journal of the Neurological Sciences|January 31, 2009
Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI studyJ M Stankiewicz, M Neema, D C Alsop, et al.
AJNR. American Journal of Neuroradiology|February 15, 2008
Segmentation of subtraction images for the measurement of lesion change in multiple sclerosisY Duan, P G Hildenbrand, M P Sampat, et al.
Neurology|September 17, 2008
CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trialV Viglietta, K Bourcier, G J Buckle, et al.
AJNR. American Journal of Neuroradiology|August 22, 2009
Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal dataM P Sampat, A M Berger, B C Healy, et al.
AJNR. American Journal of Neuroradiology|June 17, 2008
Medulla oblongata volume: a biomarker of spinal cord damage and disability in multiple sclerosisZ Liptak, A M Berger, M P Sampat, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2007
Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosisB I Glanz, C M Holland, S A Gauthier, et al.
AJNR. American Journal of Neuroradiology|March 31, 2012
The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosisA Ceccarelli, J S Jackson, S Tauhid, et al.
Journal of the Neurological Sciences|May 12, 2009
Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort studyS A Gauthier, B I Glanz, M Mandel, et al.
Neurology|August 18, 2010
HLA B*44: protective effects in MS susceptibility and MRI outcome measuresB C Healy, M Liguori, D Tran, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Neurology|August 2, 2008
MRI measures of temporoparietal regions show differential rates of atrophy during prodromal ADR S Desikan, B Fischl, H J Cabral, et al.
Journal of the Neurological Sciences|January 31, 2009
Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI studyJ M Stankiewicz, M Neema, D C Alsop, et al.
AJNR. American Journal of Neuroradiology|February 15, 2008
Segmentation of subtraction images for the measurement of lesion change in multiple sclerosisY Duan, P G Hildenbrand, M P Sampat, et al.
Neurology|September 17, 2008
CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trialV Viglietta, K Bourcier, G J Buckle, et al.
AJNR. American Journal of Neuroradiology|August 22, 2009
Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal dataM P Sampat, A M Berger, B C Healy, et al.
AJNR. American Journal of Neuroradiology|June 17, 2008
Medulla oblongata volume: a biomarker of spinal cord damage and disability in multiple sclerosisZ Liptak, A M Berger, M P Sampat, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2007
Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosisB I Glanz, C M Holland, S A Gauthier, et al.
AJNR. American Journal of Neuroradiology|March 31, 2012
The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosisA Ceccarelli, J S Jackson, S Tauhid, et al.
Journal of the Neurological Sciences|May 12, 2009
Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort studyS A Gauthier, B I Glanz, M Mandel, et al.
Neurology|August 18, 2010
HLA B*44: protective effects in MS susceptibility and MRI outcome measuresB C Healy, M Liguori, D Tran, et al.
Pageof 3